Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : John, Mike & Tom's Wild World of Stocks -- Ignore unavailable to you. Want to Upgrade?

To: wlheatmoon who wrote (253)	1/5/2000 6:55:00 PM
From: wlheatmoon	Read Replies (1) \| Respond to of 2850

Human Genome Sciences' Board of Directors Approves Two-For-One Stock Split ROCKVILLE, Md., Jan. 5 /PRNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI - news) announced today that its Board of Directors has approved a two- for-one stock split of the Company's common stock payable in the form of a 100 percent stock dividend. On Friday, January 28, 2000, stockholders will receive one additional share for every share they own as of the close of business on the record date of Friday, January 14, 2000. Human Genome Sciences will trade on a split-adjusted basis on Monday, January 31, 2000. As of January 4, 2000, before giving effect to the stock split, there were approximately 23.3 million shares outstanding.